Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine.
暂无分享,去创建一个
S. Mittelman | A. Butturini | V. Avramis | Ehsan A Ehsanipour | Xia Sheng | James W Behan | Xingchao Wang | Anna Butturini | Vassilios I Avramis | Steven D Mittelman | X. Wang | J. Behan | Ehsan A. Ehsanipour | X. Sheng | Xingchao Wang
[1] M. Elia,et al. Amino acid metabolism in human subcutaneous adipose tissue in vivo. , 1991, Clinical science.
[2] R. Pieters,et al. No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy , 2013, Pediatric blood & cancer.
[3] Guoyao Wu,et al. Regional muscle and adipose tissue amino acid metabolism in lean and obese women. , 2002, American journal of physiology. Endocrinology and metabolism.
[4] A. Spencer,et al. Asparaginase in the management of adult acute lymphoblastic leukaemia: is it used appropriately? , 2011, Cancer treatment reviews.
[5] H. Mikawa,et al. Metabolic basis for differential glutamine requirements of human leukemia cell lines , 1990, Journal of cellular physiology.
[6] K. Clément,et al. Increased Adipose Tissue Oxygen Tension in Obese Compared With Lean Men Is Accompanied by Insulin Resistance, Impaired Adipose Tissue Capillarization, and Inflammation , 2011, Circulation.
[7] R. Gelber,et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. , 2001, Blood.
[8] D. Durden,et al. Comparison of the immunosuppressive effects of asparaginases from Escherichia coli and Vibrio succinogenes. , 1980, Cancer research.
[9] David Steele,et al. Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: A Children's Oncology Group study (CCG‐1941) , 2006, Pediatric blood & cancer.
[10] M. Watford,et al. Glutamine, insulin and glucocorticoids regulate glutamine synthetase expression in C2C12 myotubes, Hep G2 hepatoma cells and 3T3 L1 adipocytes. , 2007, Biochimica et biophysica acta.
[11] D. Cooney,et al. DON, CONV and DONV-II. Inhibition of L-'asparagine synthetase in vivo. , 1976, Biochemical pharmacology.
[12] M. Scherer,et al. Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow , 2012, Journal of cellular physiology.
[13] Z. Li,et al. Epigenetic changes in the repression and induction of asparagine synthetase in human leukemic cell lines , 2005, Leukemia.
[14] Y. Song,et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone , 1997, International Journal of Obesity.
[15] R. Miller,et al. Regulation of glutamine synthetase in cultured 3T3-L1 cells by insulin, hydrocortisone, and dibutyryl cyclic AMP. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[16] O. Haas,et al. Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin–Frankfurt–Münster-based induction therapy for childhood acute lymphoblastic leukemia , 2012, Leukemia & lymphoma.
[17] B. Pollock,et al. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. , 2000, Blood.
[18] J. Boos,et al. The best way to use asparaginase in childhood acute lymphatic leukaemia – still to be defined? , 2004, British journal of haematology.
[19] R. Handschumacher,et al. Evaluation of L-asparagine metabolism in animals and man. , 1970, Cancer research.
[20] Nicola Zamboni,et al. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.
[21] R. Sherwood. Amino acid measurement in body fluids using PITC derivatives. , 2000, Methods in molecular biology.
[22] D. Durden,et al. Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase* , 2006, Journal of Biological Chemistry.
[23] G. C. Chan,et al. Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells , 2010, Leukemia & lymphoma.
[24] J. Grem,et al. Metabolism and action of amino acid analog anti-cancer agents. , 1990, Pharmacology & therapeutics.
[25] A. Bleyer,et al. Obesity and outcome in pediatric acute lymphoblastic leukemia. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] L. Tone,et al. IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase , 2012, Leukemia.
[27] A. Bendich,et al. Enzyme-induced asparagine and glutamine depletion and immune system function. , 1983, The American journal of clinical nutrition.
[28] E. S. Costa,et al. Overweight as a Prognostic Factor in Children With Acute Lymphoblastic Leukemia , 2011, Obesity.
[29] J. H. Kim,et al. Inhibition of leukemias in man by L-asparaginase. , 1967, Cancer research.
[30] P. Landrigan. Childhood leukemias. , 1995, The New England journal of medicine.
[31] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[32] M. D. Den Boer,et al. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. , 2003, Blood.
[33] V. Avramis,et al. Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia , 2006, International journal of nanomedicine.
[34] H. Müller,et al. Use of L-asparaginase in childhood ALL. , 1998, Critical reviews in oncology/hematology.
[35] C. Pui. Medical progress : childhood leukemias , 1995 .
[36] M. Kilberg,et al. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells. , 2001, The Biochemical journal.
[37] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[38] C. Thompson,et al. Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.
[39] R. Davis,et al. Inhibitors of L-asparagine synthetase, in vitro. , 1976, Cancer treatment reports.
[40] N. Heisterkamp,et al. Activity of the Aurora Kinase Inhibitor VX-680 against Bcr/Abl-Positive Acute Lymphoblastic Leukemias , 2010, Molecular Cancer Therapeutics.
[41] N. Heisterkamp,et al. Adipocytes impair leukemia treatment in mice. , 2009, Cancer research.
[42] T. Anthony,et al. Alanyl-glutamine consumption modifies the suppressive effect of L-asparaginase on lymphocyte populations in mice. , 2008, The Journal of nutrition.
[43] J. Downing,et al. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. , 2007, The Journal of clinical investigation.
[44] H. Sather,et al. Asparaginase Antibody and Asparaginase Activity in Children With Higher-Risk Acute Lymphoblastic Leukemia: Children's Cancer Group Study CCG-1961 , 2004, Journal of pediatric hematology/oncology.
[45] References , 1971 .
[46] V. V. Dasu,et al. Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428. , 2011, Bioresource technology.
[47] G. Jenster,et al. Acute leukaemia in bcr/abl transgenic mice , 1990, Nature.
[48] Marc N. Offman,et al. Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity. , 2011, Blood.
[49] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.